Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches
- PMID: 38380095
- PMCID: PMC10877060
- DOI: 10.3389/fmicb.2024.1331508
Exploring antibiotic resistance mechanisms in Mycobacterium abscessus for enhanced therapeutic approaches
Abstract
Mycobacterium abscessus, a leading cause of severe lung infections in immunocompromised individuals, poses significant challenges for current therapeutic strategies due to resistance mechanisms. Therefore, understanding the intrinsic and acquired antibiotic resistance of M. abscessus is crucial for effective treatment. This review highlights the mechanisms employed by M. abscessus to sustain antibiotic resistance, encompassing not only conventional drugs but also newly discovered drug candidates. This comprehensive analysis aims to identify novel entities capable of overcoming the notorious resistance exhibited by M. abscessus, providing insights for the development of more effective therapeutic interventions.
Keywords: Mycobacterium abscessus; drug resistance; efflux pump; intrinsic-extrinsic drug resistance; mycobacterium drug efficacy.
Copyright © 2024 Nguyen, Heo, Jeon, Ash, Lee, Moon and Jang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Arabinosyltransferase C Mediates Multiple Drugs Intrinsic Resistance by Altering Cell Envelope Permeability in Mycobacterium abscessus.Microbiol Spectr. 2022 Aug 31;10(4):e0276321. doi: 10.1128/spectrum.02763-21. Epub 2022 Aug 10. Microbiol Spectr. 2022. PMID: 35946941 Free PMC article.
-
Preclinical murine models to study lung infection with Mycobacterium abscessus complex.Tuberculosis (Edinb). 2023 Jan;138:102301. doi: 10.1016/j.tube.2022.102301. Epub 2022 Dec 29. Tuberculosis (Edinb). 2023. PMID: 36603391 Review.
-
The Role of Antibiotic-Target-Modifying and Antibiotic-Modifying Enzymes in Mycobacterium abscessus Drug Resistance.Front Microbiol. 2018 Sep 12;9:2179. doi: 10.3389/fmicb.2018.02179. eCollection 2018. Front Microbiol. 2018. PMID: 30258428 Free PMC article. Review.
-
Efflux pumps and membrane permeability contribute to intrinsic antibiotic resistance in Mycobacterium abscessus.bioRxiv [Preprint]. 2024 Aug 24:2024.08.23.609441. doi: 10.1101/2024.08.23.609441. bioRxiv. 2024. Update in: PLoS Pathog. 2025 Apr 10;21(4):e1013027. doi: 10.1371/journal.ppat.1013027. PMID: 39229117 Free PMC article. Updated. Preprint.
-
The TetR Family Transcription Factor MAB_2299c Regulates the Expression of Two Distinct MmpS-MmpL Efflux Pumps Involved in Cross-Resistance to Clofazimine and Bedaquiline in Mycobacterium abscessus.Antimicrob Agents Chemother. 2019 Sep 23;63(10):e01000-19. doi: 10.1128/AAC.01000-19. Print 2019 Oct. Antimicrob Agents Chemother. 2019. PMID: 31332077 Free PMC article.
Cited by
-
Activity of combinations of bactericidal and bacteriostatic compounds in Mycobacterium abscessus-infected mice: an overview.Front Microbiol. 2025 Aug 1;16:1616149. doi: 10.3389/fmicb.2025.1616149. eCollection 2025. Front Microbiol. 2025. PMID: 40822395 Free PMC article. Review.
-
Fate of in vitro cultured Mycobacterium abscessus populations when exposed to moxifloxacin.Front Microbiol. 2024 Nov 28;15:1494147. doi: 10.3389/fmicb.2024.1494147. eCollection 2024. Front Microbiol. 2024. PMID: 39669783 Free PMC article.
-
Efficacies of omadacycline + amikacin + imipenem and an all-oral regimen omadacycline + clofazimine + linezolid in a mouse model of M. abscessus lung disease.mSphere. 2024 Jul 30;9(7):e0038124. doi: 10.1128/msphere.00381-24. Epub 2024 Jul 9. mSphere. 2024. PMID: 38980071 Free PMC article.
-
Trehalose polyphleates participate in Mycobacterium abscessus fitness and pathogenesis.mBio. 2024 Dec 11;15(12):e0297024. doi: 10.1128/mbio.02970-24. Epub 2024 Oct 30. mBio. 2024. PMID: 39475242 Free PMC article.
-
Unusual Presentation of Mycobacteroides abscessus Thigh Mass: A Case Report.Case Rep Infect Dis. 2025 Jul 9;2025:6970929. doi: 10.1155/crdi/6970929. eCollection 2025. Case Rep Infect Dis. 2025. PMID: 40678751 Free PMC article.
References
-
- Alexander D. C., Vasireddy R., Vasireddy S., Philley J. V., Brown-Elliott B. A., Perry B. J., et al. . (2017). Emergence of mmpT5 variants during bedaquiline treatment of Mycobacterium intracellulare lung disease. J. Clin. Microbiol. 55, 574–584. doi: 10.1128/JCM.02087-16, PMID: - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Molecular Biology Databases